NEW YORK (360Dx) – Interpace Diagnostics today reported a 37 percent hike in its first quarter revenues.
For the three months ended March 31, Interpace posted $4.8 million in revenues, up from $3.5 million in the year-ago quarter, and beat the consensus Wall Street estimate of $4.3 million.